Heidemarie Kletzl
5PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 11, 2024
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam.Claudia A Chiriboga, Claudio Bruno, Tina Duong
|Apr 18, 2023
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA).Maryam Oskoui, John W Day, Nicolas Deconinck
|Feb 03, 2023
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA).Maryam Oskoui, John W Day, Nicolas Deconinck
|Mar 18, 2022
Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam.Heidemarie Kletzl, Hassan Ajmi, Izabela Antys
|Nov 17, 2020
Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.Ekaterina Gibiansky, Claire Petry, Francois Mercier
Pageof 1
Frequent Collaborators
3 joint publications
Eugenio Mercuri
3 joint publications
Paulo Fontoura
3 joint publications
Renata S Scalco
3 joint publications
Ksenija Gorni
3 joint publications
Janbernd Kirschner
3 joint publications
Anna Kostera-Pruszczyk
2 joint publications
John W Day
2 joint publications
Nicolas Deconinck
2 joint publications
Andres Nascimento
2 joint publications
Kayoko Saito
